Trials / Completed
CompletedNCT06898697
Midazolam or Fentanyl as Adjuvants to Epidural Bupivacaine Plus Dexamethasone for Analgesia
Midazolam or Fentanyl as Adjuvants to Epidural Bupivacaine Plus Dexamethasone for Analgesia After Lumbar Spine Fixation: A Randomized Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Zagazig University · Other Government
- Sex
- All
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare better postoperative analgesia after lumbar spine Fixation using either epidural bupivacaine with midazolam or fentanyl with the combination of dexamethasone.
Detailed description
After being informed about the study and potential risks. A computer-generated randomization table will randomize all patients giving written consent into 2 groups, each containing 51 patients. In the Fentanyl Group :.Patients will receive 10 ml of bupivacaine 0. 25 % plus 100µg fentanyl in 2ml plus 2ml (8mg) dexamethasone.In Midazolam Group: Patients will receive 10 ml of bupivacaine 0.25 % plus 2mg midazolam in 2ml plus 2 ml (8mg) dexamethasone
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epidural fentanyl | Fentanyl will be injected in the epidural space by the surgeon one or two levels above the surgical site. |
| DRUG | epidural midazolam | midazolam will be injected in the epidural space by the surgeon one or two levels above the surgical site. |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2025-03-27
- Last updated
- 2026-01-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06898697. Inclusion in this directory is not an endorsement.